188 related articles for article (PubMed ID: 32865574)
1. Evaluation of Drug Labels Following the 2015 Pregnancy and Lactation Labeling Rule.
Byrne JJ; Saucedo AM; Spong CY
JAMA Netw Open; 2020 Aug; 3(8):e2015094. PubMed ID: 32865574
[TBL] [Abstract][Full Text] [Related]
2. Clinicians' Perspective of the New Pregnancy and Lactation Labeling Rule (PLLR): Results from an AAAAI/FDA Survey.
Namazy J; Chambers C; Sahin L; Johnson T; Dinatale M; Lappin B; Schatz M
J Allergy Clin Immunol Pract; 2020 Jun; 8(6):1947-1952. PubMed ID: 32084595
[TBL] [Abstract][Full Text] [Related]
3. The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources.
Harris JB; Holmes AP; Eiland LS
Ann Pharmacother; 2021 Apr; 55(4):459-465. PubMed ID: 32885981
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Pregnancy and Lactation Labeling Rule (PLLR) on Practicing Dermatologists.
Beroukhim K; Abrouk M; Farahnik B
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632938
[TBL] [Abstract][Full Text] [Related]
5. The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization.
Gruber MF
Vaccine; 2015 Nov; 33(47):6499-500. PubMed ID: 26256527
[TBL] [Abstract][Full Text] [Related]
6. Medication use in pregnancy and the pregnancy and lactation labeling rule.
Sahin L; Nallani SC; Tassinari MS
Clin Pharmacol Ther; 2016 Jul; 100(1):23-5. PubMed ID: 27082701
[TBL] [Abstract][Full Text] [Related]
7. The Importance of Clinical Research in Pregnant Women to Inform Prescription Drug Labeling.
Dinatale M; Roca C; Sahin L; Johnson T; Mulugeta LY; Fletcher EP; Yao L
J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S18-S25. PubMed ID: 33274508
[TBL] [Abstract][Full Text] [Related]
8. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Brucker MC; King TL
J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of knowledge of the new Pregnancy and Lactation Labeling Rule among pharmacists and physicians.
Alem G; Awuonda M; Haastrup D; Anyiwo A; Daftary M; Wingate L; Ettienne E
J Am Pharm Assoc (2003); 2022; 62(2):427-431. PubMed ID: 34863633
[TBL] [Abstract][Full Text] [Related]
10. Trends in pregnancy labeling and data quality for US-approved pharmaceuticals.
Mazer-Amirshahi M; Samiee-Zafarghandy S; Gray G; van den Anker JN
Am J Obstet Gynecol; 2014 Dec; 211(6):690.e1-11. PubMed ID: 24912093
[TBL] [Abstract][Full Text] [Related]
11. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2014 Dec; 79(233):72063-103. PubMed ID: 25509060
[TBL] [Abstract][Full Text] [Related]
12. A Comparison of FDA and EMA Pregnancy and Lactation Labeling.
Kappel D; Sahin L; Yao L; Thor S; Kweder S
Clin Pharmacol Ther; 2023 Jun; 113(6):1251-1257. PubMed ID: 36645246
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the US Food and Drug Administration Post-Marketing Commitments and Requirements for Pregnancy and Lactation.
Avachat C; Younis IR; Birnbaum AK
Clin Pharmacol Ther; 2023 Dec; 114(6):1238-1242. PubMed ID: 37750407
[TBL] [Abstract][Full Text] [Related]
14. Introduction to the new prescription drug labeling by the Food and Drug Administration.
Lal R; Kremzner M
Am J Health Syst Pharm; 2007 Dec; 64(23):2488-94. PubMed ID: 18029957
[TBL] [Abstract][Full Text] [Related]
15. Clinical Lactation Studies of Neuropsychiatric Medications: Clinical Pharmacology and Labeling Considerations.
Nallani SC; Baisden K; Dinatale M; Basham L; Kwatra D; Yao L
J Clin Pharmacol; 2023 Jun; 63 Suppl 1():S159-S169. PubMed ID: 37317496
[TBL] [Abstract][Full Text] [Related]
16. FDA drug labeling for pregnancy and lactation drug safety monitoring systems.
Greene MF
Semin Perinatol; 2015 Nov; 39(7):520-3. PubMed ID: 26428020
[TBL] [Abstract][Full Text] [Related]
17. Availability of Safe and Effective Therapeutic Options to Pregnant and Lactating Individuals Following the United States Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Patel A; Sushko K; Mazer-Amirshahi M; Pfuma Fletcher E; Fusch G; Chan O; Aghayi A; Chan AKC; Lacaze-Masmonteil T; Van Den Anker J; Samiee-Zafarghandy S
J Pediatr; 2023 Aug; 259():113342. PubMed ID: 36806753
[TBL] [Abstract][Full Text] [Related]
18. Drug safety: Pregnancy rating classifications and controversies.
Wilmer E; Chai S; Kroumpouzos G
Clin Dermatol; 2016; 34(3):401-9. PubMed ID: 27265079
[TBL] [Abstract][Full Text] [Related]
19. Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2020 and 2021.
Barrow P
Reprod Toxicol; 2022 Sep; 112():100-108. PubMed ID: 35788364
[TBL] [Abstract][Full Text] [Related]
20. Healthcare providers' use of a concise summary to prescribe for lactating patients.
Koenig T; Robins C; Darby Lipman P; Dinatale M; Johnson T; Sahin L; Roca C; Limpert J; Baisden K; Mulugeta Y; Yao L; Jennings KA; Alimchandani M; Everett D; Gassman A; Chang C; Ellis C; Pfuma Fletcher E; Samuels S
Res Social Adm Pharm; 2024 May; 20(5):531-538. PubMed ID: 38413289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
